Search Results

You are looking at 121 - 130 of 957 items for :

  • "NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines" x
  • Refine by Access: All x
Clear All
Full access

Kristine A. Donovan, Teresa L. Deshields, Cheyenne Corbett, and Michelle B. Riba

NCCN was among the first voices calling for routine screening of distress in patients with cancer. The first NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Distress Management were published in 1999. 1 Since then, a number of

Full access

Marsha Reyngold, Joyce Niland, Anna ter Veer, Dana Milne, Tanios Bekaii-Saab, Steven J. Cohen, Lily Lai, Deborah Schrag, John M. Skibber, William Small Jr, Martin Weiser, Neal Wilkinson, and Karyn A. Goodman

Practice Guidelines in Oncology (NCCN Guidelines) for locally advanced resectable rectal cancer include neoadjuvant RT with capecitabine or concurrent 5-FU infusion, followed by TME and an adjuvant course of consolidative chemotherapy (to view the most

Full access

Sumer K. Wallace, Jeff F. Lin, William A. Cliby, Gary S. Leiserowitz, Ana I. Tergas, and Robert E. Bristow

(PFS) and overall survival (OS) in patients receiving the standard treatment of combination platinum- and taxane-based chemotherapy, as recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer. 6 – 8 As

Full access

Jashodeep Datta, Matthew T. McMillan, Eric K. Shang, Ronac Mamtani, Russell S. Lewis Jr, Rachel R. Kelz, Ursina Teitelbaum, John P. Plastaras, Jeffrey A. Drebin, Douglas L. Fraker, Giorgos C. Karakousis, and Robert E. Roses

data, current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer 10 recommend postoperative CRT for patients with localized GA 4 or postoperative chemotherapy after D2 (to view the most recent version of these

Full access

Demetra Hypatia Hufnagel, Sumit Tushar Mehta, Chinyere Ezekwe, Alaina J. Brown, Alicia Beeghly-Fadiel, and Lauren Shore Prescott

is lacking. In a prospective study of 15,000 patients with cancer, 39% had anemia at initial presentation; however, only 40% of those with anemia received treatment. 2 The current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for

Full access

Craig S. Schneider, Robert A. Oster, Aparna Hegde, Michael C. Dobelbower, John M. Stahl, and Adam J. Kole

evaluating the role of chemotherapy are lacking. As a result, based on extrapolations of surgical data, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for NSCLC recommend the consideration of chemotherapy for high-risk patients with

Full access

Paul Glare, Kathy Plakovic, Anna Schloms, Barbara Egan, Andrew S. Epstein, David Kelsen, and Leonard Saltz

. In an effort to help overcome these barriers, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Palliative Care recommend that all patients with cancer be screened for PC needs, and consultation or collaboration with a PC

Full access

David J. Worhunsky, Yifei Ma, Yulia Zak, George A. Poultsides, Jeffrey A. Norton, Kim F. Rhoads, and Brendan C. Visser

Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations based on the best evidence available at the time they are derived and on expert consensus. These guidelines are continuously updated and revised to reflect new data and

Full access

Robert J. Morgan Jr., Ronald D. Alvarez, Deborah K. Armstrong, Barry Boston, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi J. Gray, Perry W. Grigsby, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Steven W. Remmenga, Paul Sabbatini, Russell J. Schilder, Julian C. Schink, Nelson Teng, and Theresa L. Werner

be considered in treatment guidelines. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer discuss epithelial ovarian cancer (including borderline or low malignant potential) and less-common histopathologies

Full access

Robert B. Hines, Alina Barrett, Philip Twumasi-Ankrah, Dominique Broccoli, Kimberly K. Engelman, Joaquina Baranda, Elizabeth A. Ablah, Lisette Jacobson, Michelle Redmond, Wei Tu, and Tracie C. Collins

, and race on the risk of patient nonadherence with NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon/Rectal Cancer. It also assesses the effect of nonadherence to treatment guidelines and the aforementioned risk factors on